Lynne Krummen
Corporate Officer/Principal bei VIR BIOTECHNOLOGY, INC.
Profil
Lynne Krummen is currently working as the Executive VP-Product Development at Vir Biotechnology, Inc. She started this position in 2023.
Prior to her current role, she worked at Genentech, Inc. as the VP & Global Head-Biologics, Regulatory CMC from 2011 to 2018.
Dr. Krummen holds a doctorate degree from The University of Cincinnati College of Medicine.
Aktive Positionen von Lynne Krummen
| Unternehmen | Position | Beginn |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01.10.2023 |
Ehemalige bekannte Positionen von Lynne Krummen
| Unternehmen | Position | Ende |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Ausbildung von Lynne Krummen
| The University of Cincinnati College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
